Related Experiment Videos
Human chorionic gonadotropin: its possible role in maternal lymphocyte suppression
Science (New York, N.Y.)
|August 31, 1973
Summary
Human chorionic gonadotropin (hCG) prevents lymphocyte response to phytohemagglutinin. This reversible, non-toxic effect suggests hCG acts as a trophoblastic antigen, blocking maternal lymphocyte activity for fetal acceptance.
Area of Science:
- Immunology
- Reproductive Biology
- Cellular Biology
Background:
- Maternal immune tolerance to the fetus is crucial for successful pregnancy.
- The mechanisms underlying fetal immune privilege remain incompletely understood.
- Human chorionic gonadotropin (hCG) is a key hormone produced during pregnancy.
Purpose of the Study:
- To investigate the effect of human chorionic gonadotropin (hCG) on lymphocyte activation.
- To explore the potential role of hCG in maternal immune modulation during pregnancy.
Main Methods:
- Lymphocyte cultures were stimulated with phytohemagglutinin (PHA) in the presence and absence of hCG.
- The reversibility and cytotoxic effects of hCG on lymphocytes were assessed.
Main Results:
- hCG completely inhibited the PHA-induced response of lymphocytes.
- The inhibitory effect of hCG was found to be reversible.
- hCG demonstrated no cytotoxic effects on lymphocytes at the concentrations tested.
Conclusions:
- These findings support the hypothesis that hCG plays a role in maternal immune tolerance.
- hCG may function as a trophoblastic surface antigen, directly blocking maternal lymphocyte activation.
- This mechanism could explain the immunological acceptance of the fetus during pregnancy.